News & Updates

Corticosteroids lessen mechanical ventilation use in CAP
Corticosteroids lessen mechanical ventilation use in CAP
03 Jan 2025 byStephen Padilla

In critically ill patients with community-acquired pneumonia (CAP), treatment with corticosteroids has significantly reduced the need for mechanical ventilation, while use of hydrocortisone has prevented many hospital deaths.

Corticosteroids lessen mechanical ventilation use in CAP
03 Jan 2025
Ipilimumab plus nivolumab elicits response in mCRPC
Ipilimumab plus nivolumab elicits response in mCRPC
02 Jan 2025 byStephen Padilla

Use of dual immune checkpoint inhibitors (ICIs), nivolumab and ipilimumab, exhibits responses in some molecularly selected patients with metastatic castration-resistant prostate cancer (mCRPC), including those with mismatch repair deficiency (dMMR), nonsynonymous tumour mutational burden ≥7.1 muts/Mb (hTMB), a BRCA2 mutation (BRCAm), or biallelic CDK12 inactivation (CDK12i).

Ipilimumab plus nivolumab elicits response in mCRPC
02 Jan 2025
Novel vaccine passes phase II trial in virally suppressed CHB
Novel vaccine passes phase II trial in virally suppressed CHB
26 Dec 2024

Therapeutic vaccination with ChAdOx1-HBV/MVA-HBV (VTP-300) has generated CD4+ and CD8+ cells and reduced HBsAg in a subset of chronic hepatitis B (CHB) patients with baseline values <100 IU/ml, as shown in a phase Ib/IIa trial. Moreover, a significant decrease in surface antigen occurs when the vaccine is combined with low-dose nivolumab.

Novel vaccine passes phase II trial in virally suppressed CHB
26 Dec 2024